2024-09-01 2025-08-31 2025-08-31 false SC707668 OCCAM BIOSCIENCES LIMITED 2025-10-28 72110 false iso4217:GBP xbrli:pure SC707668 2024-08-31 SC707668 2025-08-31 SC707668 2024-09-01 2025-08-31 SC707668 2023-08-31 SC707668 2024-08-31 SC707668 2023-09-01 2024-08-31 SC707668 bus:SmallEntities 2024-09-01 2025-08-31 SC707668 bus:AuditExempt-NoAccountantsReport 2024-09-01 2025-08-31 SC707668 bus:AbridgedAccounts 2024-09-01 2025-08-31 SC707668 bus:PrivateLimitedCompanyLtd 2024-09-01 2025-08-31 SC707668 core:WithinOneYear 2025-08-31 SC707668 core:AfterOneYear 2025-08-31 SC707668 core:WithinOneYear 2024-08-31 SC707668 core:AfterOneYear 2024-08-31 SC707668 core:ShareCapital 2025-08-31 SC707668 core:SharePremium 2025-08-31 SC707668 core:RevaluationReserve 2025-08-31 SC707668 core:OtherReservesSubtotal 2025-08-31 SC707668 core:RetainedEarningsAccumulatedLosses 2025-08-31 SC707668 core:ShareCapital 2024-08-31 SC707668 core:SharePremium 2024-08-31 SC707668 core:RevaluationReserve 2024-08-31 SC707668 core:OtherReservesSubtotal 2024-08-31 SC707668 core:RetainedEarningsAccumulatedLosses 2024-08-31 SC707668 core:LandBuildings 2025-08-31 SC707668 core:PlantMachinery 2025-08-31 SC707668 core:Vehicles 2025-08-31 SC707668 core:FurnitureFittings 2025-08-31 SC707668 core:OfficeEquipment 2025-08-31 SC707668 core:NetGoodwill 2025-08-31 SC707668 core:IntangibleAssetsOtherThanGoodwill 2025-08-31 SC707668 core:ListedExchangeTraded 2025-08-31 SC707668 core:UnlistedNon-exchangeTraded 2025-08-31 SC707668 core:LandBuildings 2024-08-31 SC707668 core:PlantMachinery 2024-08-31 SC707668 core:Vehicles 2024-08-31 SC707668 core:FurnitureFittings 2024-08-31 SC707668 core:OfficeEquipment 2024-08-31 SC707668 core:NetGoodwill 2024-08-31 SC707668 core:IntangibleAssetsOtherThanGoodwill 2024-08-31 SC707668 core:ListedExchangeTraded 2024-08-31 SC707668 core:UnlistedNon-exchangeTraded 2024-08-31 SC707668 core:LandBuildings 2024-09-01 2025-08-31 SC707668 core:PlantMachinery 2024-09-01 2025-08-31 SC707668 core:Vehicles 2024-09-01 2025-08-31 SC707668 core:FurnitureFittings 2024-09-01 2025-08-31 SC707668 core:OfficeEquipment 2024-09-01 2025-08-31 SC707668 core:NetGoodwill 2024-09-01 2025-08-31 SC707668 core:IntangibleAssetsOtherThanGoodwill 2024-09-01 2025-08-31 SC707668 core:ListedExchangeTraded 2024-09-01 2025-08-31 SC707668 core:UnlistedNon-exchangeTraded 2024-09-01 2025-08-31 SC707668 core:MoreThanFiveYears 2024-09-01 2025-08-31 SC707668 core:Non-currentFinancialInstruments 2025-08-31 SC707668 core:Non-currentFinancialInstruments 2024-08-31 SC707668 dpl:CostSales 2024-09-01 2025-08-31 SC707668 dpl:DistributionCosts 2024-09-01 2025-08-31 SC707668 core:LandBuildings 2024-09-01 2025-08-31 SC707668 core:PlantMachinery 2024-09-01 2025-08-31 SC707668 core:Vehicles 2024-09-01 2025-08-31 SC707668 core:FurnitureFittings 2024-09-01 2025-08-31 SC707668 core:OfficeEquipment 2024-09-01 2025-08-31 SC707668 dpl:AdministrativeExpenses 2024-09-01 2025-08-31 SC707668 core:NetGoodwill 2024-09-01 2025-08-31 SC707668 core:IntangibleAssetsOtherThanGoodwill 2024-09-01 2025-08-31 SC707668 dpl:GroupUndertakings 2024-09-01 2025-08-31 SC707668 dpl:ParticipatingInterests 2024-09-01 2025-08-31 SC707668 dpl:GroupUndertakings core:ListedExchangeTraded 2024-09-01 2025-08-31 SC707668 core:ListedExchangeTraded 2024-09-01 2025-08-31 SC707668 dpl:GroupUndertakings core:UnlistedNon-exchangeTraded 2024-09-01 2025-08-31 SC707668 core:UnlistedNon-exchangeTraded 2024-09-01 2025-08-31 SC707668 dpl:CostSales 2023-09-01 2024-08-31 SC707668 dpl:DistributionCosts 2023-09-01 2024-08-31 SC707668 core:LandBuildings 2023-09-01 2024-08-31 SC707668 core:PlantMachinery 2023-09-01 2024-08-31 SC707668 core:Vehicles 2023-09-01 2024-08-31 SC707668 core:FurnitureFittings 2023-09-01 2024-08-31 SC707668 core:OfficeEquipment 2023-09-01 2024-08-31 SC707668 dpl:AdministrativeExpenses 2023-09-01 2024-08-31 SC707668 core:NetGoodwill 2023-09-01 2024-08-31 SC707668 core:IntangibleAssetsOtherThanGoodwill 2023-09-01 2024-08-31 SC707668 dpl:GroupUndertakings 2023-09-01 2024-08-31 SC707668 dpl:ParticipatingInterests 2023-09-01 2024-08-31 SC707668 dpl:GroupUndertakings core:ListedExchangeTraded 2023-09-01 2024-08-31 SC707668 core:ListedExchangeTraded 2023-09-01 2024-08-31 SC707668 dpl:GroupUndertakings core:UnlistedNon-exchangeTraded 2023-09-01 2024-08-31 SC707668 core:UnlistedNon-exchangeTraded 2023-09-01 2024-08-31 SC707668 core:NetGoodwill 2025-08-31 SC707668 core:IntangibleAssetsOtherThanGoodwill 2025-08-31 SC707668 core:LandBuildings 2025-08-31 SC707668 core:PlantMachinery 2025-08-31 SC707668 core:Vehicles 2025-08-31 SC707668 core:FurnitureFittings 2025-08-31 SC707668 core:OfficeEquipment 2025-08-31 SC707668 core:AfterOneYear 2025-08-31 SC707668 core:WithinOneYear 2025-08-31 SC707668 core:ListedExchangeTraded 2025-08-31 SC707668 core:UnlistedNon-exchangeTraded 2025-08-31 SC707668 core:ShareCapital 2025-08-31 SC707668 core:SharePremium 2025-08-31 SC707668 core:RevaluationReserve 2025-08-31 SC707668 core:OtherReservesSubtotal 2025-08-31 SC707668 core:RetainedEarningsAccumulatedLosses 2025-08-31 SC707668 core:NetGoodwill 2024-08-31 SC707668 core:IntangibleAssetsOtherThanGoodwill 2024-08-31 SC707668 core:LandBuildings 2024-08-31 SC707668 core:PlantMachinery 2024-08-31 SC707668 core:Vehicles 2024-08-31 SC707668 core:FurnitureFittings 2024-08-31 SC707668 core:OfficeEquipment 2024-08-31 SC707668 core:AfterOneYear 2024-08-31 SC707668 core:WithinOneYear 2024-08-31 SC707668 core:ListedExchangeTraded 2024-08-31 SC707668 core:UnlistedNon-exchangeTraded 2024-08-31 SC707668 core:ShareCapital 2024-08-31 SC707668 core:SharePremium 2024-08-31 SC707668 core:RevaluationReserve 2024-08-31 SC707668 core:OtherReservesSubtotal 2024-08-31 SC707668 core:RetainedEarningsAccumulatedLosses 2024-08-31 SC707668 core:NetGoodwill 2023-08-31 SC707668 core:IntangibleAssetsOtherThanGoodwill 2023-08-31 SC707668 core:LandBuildings 2023-08-31 SC707668 core:PlantMachinery 2023-08-31 SC707668 core:Vehicles 2023-08-31 SC707668 core:FurnitureFittings 2023-08-31 SC707668 core:OfficeEquipment 2023-08-31 SC707668 core:AfterOneYear 2023-08-31 SC707668 core:WithinOneYear 2023-08-31 SC707668 core:ListedExchangeTraded 2023-08-31 SC707668 core:UnlistedNon-exchangeTraded 2023-08-31 SC707668 core:ShareCapital 2023-08-31 SC707668 core:SharePremium 2023-08-31 SC707668 core:RevaluationReserve 2023-08-31 SC707668 core:OtherReservesSubtotal 2023-08-31 SC707668 core:RetainedEarningsAccumulatedLosses 2023-08-31 SC707668 core:AfterOneYear 2024-09-01 2025-08-31 SC707668 core:WithinOneYear 2024-09-01 2025-08-31 SC707668 core:Non-currentFinancialInstruments core:CostValuation 2024-09-01 2025-08-31 SC707668 core:Non-currentFinancialInstruments core:AdditionsToInvestments 2024-09-01 2025-08-31 SC707668 core:Non-currentFinancialInstruments core:RevaluationsIncreaseDecreaseInInvestments 2024-09-01 2025-08-31 SC707668 core:Non-currentFinancialInstruments core:DisposalsDecreaseInInvestments 2024-09-01 2025-08-31 SC707668 core:Non-currentFinancialInstruments core:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments 2024-09-01 2025-08-31 SC707668 core:Non-currentFinancialInstruments core:ImpairmentLossReversalProvisionsForImpairmentInvestments 2024-09-01 2025-08-31 SC707668 core:Non-currentFinancialInstruments core:AcquisitionsIncreaseInProvisionsForImpairmentInvestments 2024-09-01 2025-08-31 SC707668 core:Non-currentFinancialInstruments core:DisposalsDecreaseInProvisionsForImpairmentInvestments 2024-09-01 2025-08-31 SC707668 core:Non-currentFinancialInstruments core:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments 2024-09-01 2025-08-31 SC707668 core:Non-currentFinancialInstruments core:CostValuation 2025-08-31 SC707668 core:Non-currentFinancialInstruments core:AdditionsToInvestments 2025-08-31 SC707668 core:Non-currentFinancialInstruments core:RevaluationsIncreaseDecreaseInInvestments 2025-08-31 SC707668 core:Non-currentFinancialInstruments core:DisposalsDecreaseInInvestments 2025-08-31 SC707668 core:Non-currentFinancialInstruments core:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments 2025-08-31 SC707668 core:Non-currentFinancialInstruments core:ImpairmentLossReversalProvisionsForImpairmentInvestments 2025-08-31 SC707668 core:Non-currentFinancialInstruments core:AcquisitionsIncreaseInProvisionsForImpairmentInvestments 2025-08-31 SC707668 core:Non-currentFinancialInstruments core:DisposalsDecreaseInProvisionsForImpairmentInvestments 2025-08-31 SC707668 core:Non-currentFinancialInstruments core:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments 2025-08-31 SC707668 core:Non-currentFinancialInstruments core:CostValuation 2024-08-31 SC707668 core:Non-currentFinancialInstruments core:AdditionsToInvestments 2024-08-31 SC707668 core:Non-currentFinancialInstruments core:RevaluationsIncreaseDecreaseInInvestments 2024-08-31 SC707668 core:Non-currentFinancialInstruments core:DisposalsDecreaseInInvestments 2024-08-31 SC707668 core:Non-currentFinancialInstruments core:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments 2024-08-31 SC707668 core:Non-currentFinancialInstruments core:ImpairmentLossReversalProvisionsForImpairmentInvestments 2024-08-31 SC707668 core:Non-currentFinancialInstruments core:AcquisitionsIncreaseInProvisionsForImpairmentInvestments 2024-08-31 SC707668 core:Non-currentFinancialInstruments core:DisposalsDecreaseInProvisionsForImpairmentInvestments 2024-08-31 SC707668 core:Non-currentFinancialInstruments core:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments 2024-08-31 SC707668 bus:Director1 2024-09-01 2025-08-31 SC707668 bus:Director2 2024-09-01 2025-08-31

OCCAM BIOSCIENCES LIMITED

Registered Number
SC707668
(Scotland)

Unaudited Financial Statements for the Year ended
31 August 2025

OCCAM BIOSCIENCES LIMITED
Company Information
for the year from 1 September 2024 to 31 August 2025

Directors | SULLIVAN, Gareth John
| SØNSTEBØ, David

Registered Address | Prospect Ii Prospect Business Centre
| Gemini Crescent, Dundee Technology Park
| Dundee
| DD2 1TY

Registered Number | SC707668 (Scotland)

OCCAM BIOSCIENCES LIMITED
Balance Sheet as at
31 August 2025

| Notes | 2025 |  | 2024
--- | --- | --- | --- | ---
|  | £ |  | £ |  | £ |  | £
Fixed assets |  |  |  |  |  |  |  |
Intangible assets | 3 |  |  | 2,181 |  |  |  | 4,257
Tangible assets | 4 |  |  | 356,013 |  |  |  | 466,281
|  |  |  | 358,194 |  |  |  | 470,538
Current assets |  |  |  |  |  |  |  |
Debtors | 6 | 201,111 |  |  |  | 431,062 |  |
Cash at bank and on hand |  | 113,976 |  |  |  | 509,178 |  |
|  | 315,087 |  |  |  | 940,240 |  |
Creditors amounts falling due within one year | 7 | (3,878,087) |  |  |  | (3,863,042) |  |
Net current assets (liabilities) |  |  |  | (3,563,000) |  |  |  | (2,922,802)
Total assets less current liabilities |  |  |  | (3,204,806) |  |  |  | (2,452,264)
Net assets |  |  |  | (3,204,806) |  |  |  | (2,452,264)
Capital and reserves |  |  |  |  |  |  |  |
Called up share capital |  |  |  | 1,000 |  |  |  | 1,000
Profit and loss account |  |  |  | (3,205,806) |  |  |  | (2,453,264)
Shareholders' funds |  |  |  | (3,204,806) |  |  |  | (2,452,264)

- The company was entitled to exemption from audit for this reporting period under section 477 of the Companies Act 2006 relating to small companies.
- The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
- The Directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
- These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.
- The directors have chosen to not file a copy of the company’s profit and loss account under section 444 (5A) Companies Act 2006.
- The members have agreed to the preparation of abridged accounts for this accounting period in accordance with section 444(2A).

The financial statements were approved and authorised for issue by the Board of Directors on 28 October 2025, and are signed on its behalf by:
SULLIVAN, Gareth John Director Registered Company No. SC707668

OCCAM BIOSCIENCES LIMITED
Notes to the Financial Statements
for the year ended 31 August 2025

1. | Accounting policies
--- | ---

| Statutory information
--- | ---
| The company is a private company limited by shares and registered in Scotland. The company's registered number and registered office address can be found on the Company Information page.

| Statement of compliance
--- | ---
| The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.

| Basis of preparation
--- | ---
| The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).

| Functional and presentation currency
--- | ---
| The financial statements are presented in sterling and this is the functional currency of the company.

| Going concern
--- | ---
| After reviewing the company's forecasts and projections, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. The company therefore continues to adopt the going concern basis of accounting in preparing its financial statements.

| Turnover policy
--- | ---
| Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services.

| Revenue from sale of goods
--- | ---
| Revenue from the sale of goods is recognised when the company has transferred to the buyer the significant risks and rewards of ownership of the goods, usually when goods are delivered and legal title has passed. Providing the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the company and the costs incurred or to be incurred in respect of the transition can be measured reliably.

| Operating leases
--- | ---
| Where, substantially, all the risks and rewards of ownership of the asset do not transfer from the lessor to the company, the lease is treated as an operating lease. Rentals payable under operating leases are charged to the profit and loss account on a straight-line basis over the period of the lease.

| Employee benefits
--- | ---
| Short-term employee benefits are measured at the undiscounted amount expected to be paid in exchange for the employee's services to the company. Where employees have accrued short-term benefits which the entity has not paid by the balance sheet date, an accrual is recognised within creditors: amounts falling due within one year together with an associated expense in profit or loss. The liabilities are classified as current obligations in the statement of financial position because they are expected to be settled wholly within twelve months after the end of the period.

| Defined contribution pension plan
--- | ---
| The company operates a defined contribution pension plan for the benefit of its employees. Contributions are recognised as expenses as they become payable. Differences between contributions payable in the year and those actually paid are recognised as either prepayments or accruals in the balance sheet. The assets of the defined contribution pension scheme are held separately from those of the company in an independently administered fund.

| Foreign currency translation
--- | ---
| Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.

| Current taxation
--- | ---
| Current tax is recognised in profit or loss, except for taxes related to revaluations of land and buildings which are recognised in other comprehensive income. Current tax represents the amount of tax payable (receivable) in respect of taxable profit (loss) for the current, or past, reporting periods. Current tax is measured at the amount expected to be paid (recovered) using the tax rates and laws which have been enacted, or substantively enacted, by the balance sheet date. Where payments to HM Revenue and Customs exceed liabilities owed, an asset is recognised to the extent of the amount of tax recoverable.

| Deferred tax
--- | ---
| Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.

| Intangible assets
--- | ---
| Intangible assets are stated at cost less accumulated amortisation and accumulated impairment losses. The assets are reviewed for impairment if the above factors indicate that the carrying amount may be impaired. Amortisation is included in 'administrative expenses' in the profit and loss account.

| Tangible fixed assets and depreciation
--- | ---
| All fixed assets are initially recorded at cost. Property, plant and equipment is used in the company's principal activity for the production and supply of goods or for administrative purposes and is stated in the balance sheet under the historic cost model. This model requires the assets to be stated at cost less amounts in respect of depreciation and less any accumulated impairment losses. Depreciation is calculated so as to write off the cost of an asset, less its estimated residual value (which is the expected amount that would currently be obtained from disposal of an asset, after deducting the estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life), over the useful economic life of the respective asset as follows:

|  | Reducing balance (%) |  | Straight line (years)
| Plant and machinery | 25 |  | -
| Fixtures and fittings | 25 |  | -
| Office Equipment | - |  | 3

| Impairment of non-financial assets policy
--- | ---
| Assets which are not carried at fair value are reviewed for evidence of impairment at each reporting date. Where the asset is showing indicators of impairment, the recoverable amount of the asset, is estimated and then compared to the carrying value in the financial statements. Where the carrying amount is in excess of recoverable amount, an impairment loss is recognised in profit or loss.

| Trade and other debtors
--- | ---
| Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.

| Cash and cash equivalents
--- | ---
| Cash and cash equivalents comprise cash at bank and on hand, demand deposits with banks and other short-term highly liquid investments with original maturities of three months or less. Bank overdrafts are disclosed separately. For the purpose of the cash flow statement, bank overdrafts form an integral part of the company's cash management and are included as a component of cash and cash equivalents.

| Trade and other creditors
--- | ---
| Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.

| Financial instruments
--- | ---
| A financial asset or a financial liability is recognised only when the entity becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at transaction price and measured at amortised cost using the effective interest method. Where investments in non-derivative financial instruments are publicly traded, or their fair value can otherwise be measured reliably, the investment is subsequently measured at fair value through profit and loss. All other investments are subsequently measured at cost less impairment. Financial assets which are measured at cost or amortised cost are reviewed for objective evidence of impairment at each balance sheet date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately. All equity instruments, regardless of significance, and other financial assets that are individually significant, are assessed individually for impairment.

| Related parties
--- | ---
| For the purposes of these financial statements, a related party could be a person or an entity. Careful consideration is given to the definition of a related party to ensure that all related party relationships, transactions and balances are identified. Included in other creditors at the year-end is a balance due to David Sonstebo, director of £3,802,647. The balance is interest free and has no fixed terms of repayment.

| Government grants or assistance
--- | ---
| Government grants are recognised at the fair value of the asset received or receivable when there is reasonable assurance that the grant conditions will be met and the grants will be received. A grant that specifies performance conditions is recognised in income when the performance conditions are met. Where a grant does not specify performance conditions it is recognised in income when the proceeds are received or receivable. A grant received before the recognition criteria are satisfied is recognised as a liability.

2. | Average number of employees
--- | ---

|  | 2025 |  | 2024
| Average number of employees during the year | 9 |  | 11

3. | Intangible assets
--- | ---

|  | Total
--- | --- | ---
|  | £
| Cost or valuation
| At 01 September 24 | 4,257
| At 31 August 25 | 4,257
| Amortisation and impairment
| Charge for year | 2,076
| At 31 August 25 | 2,076
| Net book value
| At 31 August 25 | 2,181
| At 31 August 24 | 4,257

4. | Tangible fixed assets
--- | ---

|  | Total
--- | --- | ---
|  | £
| Cost or valuation
| At 01 September 24 | 931,832
| Additions | 8,137
| At 31 August 25 | 939,969
| Depreciation and impairment
| At 01 September 24 | 465,550
| Charge for year | 118,406
| At 31 August 25 | 583,956
| Net book value
| At 31 August 25 | 356,013
| At 31 August 24 | 466,281

5. | Impairment of tangible fixed assets
--- | ---
| At each reporting period end date, the company reviews the carrying amounts of its tangible and intangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs. Recoverable amount is the higher of fair value less costs to sell and value in use. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset for which the estimates of future cash flows have not been adjusted. If the recoverable amount of an asset (or cash-generating unit) is estimated to be less than its carrying amount, the carrying amount of the asset (or cash-generating unit) is reduced to its recoverable amount. An impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the impairment loss is treated as a revaluation decrease. Recognised impairment losses are reversed if, and only if, the reasons for the impairment loss have ceased to apply. Where an impairment loss subsequently reverses, the carrying amount of the asset (or cash-generating unit) is increased to the revised estimate of its recoverable amount, but so that the increased carrying amount does not exceed the carrying amount that would have been determined had no impairment loss been recognised for the asset (or cash-generating unit) in prior years. A reversal of an impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the reversal of the impairment loss is treated as a revaluation increase.

6. | Debtors: amounts due within one year
--- | ---

|  | 2025 |  | 2024
--- | --- | --- | --- | ---
|  | £ |  | £
| Trade debtors / trade receivables | 6,212 |  | 4,578
| Other debtors | 163,821 |  | 395,407
| Prepayments and accrued income | 31,078 |  | 31,077
| Total | 201,111 |  | 431,062

7. | Creditors: amounts due within one year
--- | ---

|  | 2025 |  | 2024
--- | --- | --- | --- | ---
|  | £ |  | £
| Trade creditors / trade payables | 44,334 |  | 29,289
| Other creditors | 3,802,647 |  | 3,802,647
| Accrued liabilities and deferred income | 31,106 |  | 31,106
| Total | 3,878,087 |  | 3,863,042